A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors

Michael Giuffre, Annette D. Lista, Nick Paulson, Lorianne Masuoka

Open source

DOI
10.1002/cpdd.1534
Published
2025-04-16
Container
Clinical Pharmacology in Drug Development
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpdd.1534,
  title = {A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors},
  author = {Michael Giuffre and Annette D. Lista and Nick Paulson and Lorianne Masuoka},
  year = {2025},
  journal = {Clinical Pharmacology in Drug Development},
  doi = {10.1002/cpdd.1534},
  url = {https://doi.org/10.1002/cpdd.1534}
}

RIS

TY  - JOUR
TI  - A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors
AU  - Michael Giuffre
AU  - Annette D. Lista
AU  - Nick Paulson
AU  - Lorianne Masuoka
PY  - 2025
JO  - Clinical Pharmacology in Drug Development
DO  - 10.1002/cpdd.1534
UR  - https://doi.org/10.1002/cpdd.1534
ER  - 

APA

Giuffre, M., Lista, A. D., Paulson, N., & Masuoka, L. (2025). A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.1534

Source records